Kewaunee Scientific Corporation (KEQU) financial statements and ratios from SEC XBRL: revenue $282.00M (TTM), net margin 3.4%, revenue growth 17.3% YoY, P/E 13.8. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $282.00M |
| Net Margin | 3.4% |
| Revenue Growth (YoY) | 17.3% |
| EPS Growth (YoY) | -15.6% |
| FCF Growth (YoY) | 16.5% |
| P/E Ratio | 13.8 |
| EV / EBITDA | 5.0 |
| Price / Book | 1.36 |
| Price / Sales | 0.38 |
| FCF Yield | 20.3% |
| DCF Value (model) | $65.20 |
| DCF Upside vs Price | 78.8% |
| Altman Z-Score | 3.43 (safe) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Technology) | 33.9 |
KEQU overview · KEQU earnings · KEQU KPIs · KEQU investor relations · KEQU ownership · KEQU peers · KEQU filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.